最新報告指出全球癌症醫療資源分配不均
New report finds unequal access to cancer care worldwide
Updated at: July 20, 2026 at 12:15 AM
隨著我們進入醫學創新的「黃金時代」，一個驚人的悖論出現了：儘管癌症科學突飛猛進，但全球對拯救生命治療的可及性仍存在極大不平等。
As we enter a 'golden age' of medical innovation, a startling paradox has emerged: while cancer science advances rapidly, global access to life-saving treatment remains deeply unequal.
近期一份報告強調，現代腫瘤學的益處並未獲得公平共享，導致富裕國家與低收入國家之間的差距日益擴大。
A recent report highlights that the benefits of modern oncology are not being shared equitably, creating a widening gap between wealthy and low-income nations.
最重大的挑戰之一是醫療專業人員嚴重短缺。
One of the most significant challenges is the severe shortage of medical professionals.
這種差異在醫病比上體現得尤為明顯：富裕國家平均每 256 例新病例就有一位腫瘤科醫師，而低收入國家則往往是一位醫師需服務超過 7,000 名患者。
This disparity is starkly illustrated by patient-to-physician ratios: while a wealthy nation might have one oncologist for every 256 new cases, lower-income countries often see one doctor serving over 7,000 patients.
除了人力配置問題，諸如昂貴的免疫療法等經濟障礙，以及研究偏向西方人口的傾向，都加劇了這場危機。
Beyond staffing, economic barriers like prohibitively expensive immunotherapies and a research bias toward Western populations exacerbate the crisis.
因此，在已開發國家癌症死亡率趨於穩定之際，低收入地區的死亡率卻持續攀升。
Consequently, while cancer mortality rates are stabilizing in developed nations, they continue to rise in lower-income regions.
預計到 2040 年，全球每年癌症病例將達到 2,840 萬例，專家主張優質護理必須被視為一項基本人權。
With global cancer cases projected to hit 28.4 million annually by 2040, experts argue that high-quality care must be treated as a fundamental human right.
